Atomistry » Fluorine » PDB 4c6l-4cqj » 4c9x
Atomistry »
  Fluorine »
    PDB 4c6l-4cqj »
      4c9x »

Fluorine in PDB 4c9x: Crystal Structure of NUDT1 (MTH1) with S-Crizotinib

Enzymatic activity of Crystal Structure of NUDT1 (MTH1) with S-Crizotinib

All present enzymatic activity of Crystal Structure of NUDT1 (MTH1) with S-Crizotinib:
3.6.1.55; 3.6.1.56;

Protein crystallography data

The structure of Crystal Structure of NUDT1 (MTH1) with S-Crizotinib, PDB code: 4c9x was solved by J.M.Elkins, E.Salah, M.Vollmar, K.Huber, G.Superti-Furga, K.R.Abdul Azeez, T.Krojer, F.Von Delft, C.Bountra, A.Edwards, S.Knapp, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.71 / 1.20
Space group P 2 21 21
Cell size a, b, c (Å), α, β, γ (°) 36.200, 60.020, 67.000, 90.00, 90.00, 90.00
R / Rfree (%) 14.629 / 18.159

Other elements in 4c9x:

The structure of Crystal Structure of NUDT1 (MTH1) with S-Crizotinib also contains other interesting chemical elements:

Chlorine (Cl) 3 atoms

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of NUDT1 (MTH1) with S-Crizotinib (pdb code 4c9x). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of NUDT1 (MTH1) with S-Crizotinib, PDB code: 4c9x:

Fluorine binding site 1 out of 1 in 4c9x

Go back to Fluorine Binding Sites List in 4c9x
Fluorine binding site 1 out of 1 in the Crystal Structure of NUDT1 (MTH1) with S-Crizotinib


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of NUDT1 (MTH1) with S-Crizotinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1157

b:35.1
occ:0.75
F A:VHS1157 0.0 35.1 0.8
C12 A:VHS1157 1.3 23.5 0.8
CE A:MET81 2.2 16.6 0.2
C2 A:VHS1157 2.3 23.5 0.8
C18 A:VHS1157 2.3 20.3 0.8
CL2 A:VHS1157 2.8 26.6 0.8
CG2 A:VAL83 3.1 10.2 1.0
O A:HOH2022 3.3 42.3 1.0
CB A:TYR7 3.3 10.5 1.0
CG A:TYR7 3.4 11.6 1.0
C3 A:VHS1157 3.6 22.2 0.8
C17 A:VHS1157 3.6 16.5 0.8
CD2 A:TYR7 3.7 12.4 1.0
CD1 A:TYR7 3.9 13.2 1.0
SD A:MET81 3.9 19.9 0.8
SD A:MET81 4.0 16.1 0.2
C13 A:VHS1157 4.1 19.5 0.8
CG1 A:VAL83 4.1 10.8 1.0
CB A:VAL83 4.2 9.0 1.0
CE2 A:PHE72 4.3 9.0 0.2
CE2 A:TYR7 4.5 14.4 1.0
CD2 A:PHE72 4.5 8.6 0.2
CB A:MET81 4.6 11.9 0.2
CB A:MET81 4.6 11.5 0.8
CE1 A:TYR7 4.7 16.6 1.0
CG A:MET81 4.8 14.0 0.2
CA A:TYR7 4.8 9.4 1.0
C21 A:VHS1157 4.8 14.5 0.8
CG A:MET81 4.9 14.0 0.8
CE2 A:PHE72 4.9 18.3 0.8
CZ A:TYR7 4.9 15.2 1.0
CD2 A:PHE72 4.9 15.8 0.8
O A:HOH2016 4.9 35.7 1.0

Reference:

K.V.M.Huber, E.Salah, B.Radic, M.Gridling, J.M.Elkins, A.Stukalov, A.Jemth, C.Gokturk, K.Sanjiv, K.Stromberg, T.Pham, U.W.Berglund, J.Colinge, K.L.Bennett, J.I.Loizou, T.Helleday, S.Knapp, G.Superti-Furga. Stereospecific Targeting of MTH1 By (S)-Crizotinib As An Anticancer Strategy. Nature V. 508 222 2014.
ISSN: ISSN 0028-0836
PubMed: 24695225
DOI: 10.1038/NATURE13194
Page generated: Sun Dec 13 12:00:13 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy